ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

WINT Windtree Therapeutics Inc

0.335
-0.0048 (-1.41%)
After Hours
Last Updated: 18:00:41
Delayed by 15 minutes

Period:

Draw Mode:

Volume 479,417
Bid Price 0.3301
Ask Price 0.335
News -
Day High 0.3599

Low
0.2654

52 Week Range

High
7.79

Day Low 0.33
Company Name Stock Ticker Symbol Market Type
Windtree Therapeutics Inc WINT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0048 -1.41% 0.335 18:00:41
Open Price Low Price High Price Close Price Prev Close
0.3499 0.33 0.3599 0.3418 0.3398
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
39,770 479,417 $ 0.3477534 $ 166,719 - 0.2654 - 7.79
Last Trade Time Type Quantity Stock Price Currency
18:03:18 1 $ 0.3344 USD

Windtree Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.75M 5.15M - 0 -39.21M -7.62 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Windtree Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No WINT Message Board. Create One! See More Posts on WINT Message Board See More Message Board Posts

Historical WINT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.3860.48310.26540.3741594583,787-0.051-13.21%
1 Month0.360.48310.26540.3798459236,210-0.025-6.94%
3 Months0.450.48310.26540.3808114178,233-0.115-25.56%
6 Months1.291.310.26540.5386323209,659-0.955-74.03%
1 Year7.557.790.26541.47306,051-7.22-95.56%
3 Years106.95170.000.265450.411,020,666-106.62-99.69%
5 Years347.50503.000.265455.26811,669-347.17-99.90%

Windtree Therapeutics Description

Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes synthetic, peptide-containing surfactant and novel drug delivery technologies that deliver aerosolized KL4 surfactants without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF which is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products.

Your Recent History

Delayed Upgrade Clock